MMP19 and Hyperkalemia: The univariable analysis showed similar results, however combination BB + RASi also showed a statistically significant association with the development of hyperkalemia with (OR, 1.57 [95% CI, 1.22–2.01]) within 90 days of initiating treatment (Supplementary Fig. 3).